Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.2300 (1.98%) ($40.2300 - $40.2300) on Mon. Jun. 7, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.19% (three month average) | RSI | 35 | Latest Price | $40.2300(1.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.6% a day on average for past five trading days. | Weekly Trend | HALO declines -3.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(50%) IWM(48%) IWC(44%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.095% in a week (0% probabilities). VIXM(-31%) VXX(-12%) UUP(-11%) GLD(-1%) TLT(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.095% (StdDev 2.19%) | Hourly BBV | 2.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $33.17(-17.55%) | Resistance Level | $41.75 | 5 Day Moving Average | $39.8(1.08%) | 10 Day Moving Average | $40.77(-1.32%) | 20 Day Moving Average | $41.75(-3.64%) | To recent high | -21.4% | To recent low | 3.6% | Market Cap | $5.498b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |